Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate

International Journal of Molecular Sciences

Volumn 14, Issue 8, 2013, Pages 15755-15766

  Zhu, Xiu Liang ^a   Du, Yong Zhong ^b   Yu, Ri Sheng ^a   Liu, Ping ^b   Shi, Dan ^a   Chen, Ying ^a   Wang, Ying ^a   Huang, Fang Fang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Adenosine triphosphate; Galactosylated chitosan oligosaccharide; Hepatocyte uptake; Nanoparticles; Targeted drug delivery

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATE; ASIALOGLYCOPROTEIN RECEPTOR; DRUG CARRIER; GALACTOSYLATED CHITOSAN OLIGOSACCHARIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CELL SURFACE; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; DRUG SPECIFICITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER CELL CARCINOMA; MOLECULARLY TARGETED THERAPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; STRUCTURE ANALYSIS; ZETA POTENTIAL;

ADENOSINE TRIPHOSPHATE; ASIALOGLYCOPROTEIN RECEPTOR; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; GALACTOSE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NANOPARTICLES;

EID: 84881156379     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140815755     Document Type: Article

References (37)

1. Wang, X.; Yang, L.; Chen, Z.G.; Shin, D.M. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin. 2008, 58, 97-110.
2. O'Farrell, N.; Houlton, A.; Horrocks, B.R. Silicon nanoparticles: Applications in cell biology and medicine. Int. J. Nanomed. 2006, 1, 451-472.
3. Torigian, D.A.; Huang, S.S.; Houseni, M.; Alavi, A. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J. Clin. 2007, 57, 206-224.
4. Bhattacharjee, S.; Ershov, D.; Gucht, J.V.; Alink, G.M.; Rietjens, I.M.; Zuilhof, H.; Marcelis, A.T. Surface charge-specific cytotoxicity and cellular uptake of tri-block copolymer nanoparticles. Nanotoxicology 2013, 7, 71-84.
5. Irvine, D.J. Drug delivery: One nanoparticle, one kill. Nat. Mater. 2011, 10, 342-343.
6. Mi, F.L.; Wu, Y.Y.; Chiu, Y.L.; Chen, M.C.; Sung, H.W.; Yu, S.H.; Shyu, S.S.; Huang, M.F. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells. Biomacromolecules 2007, 8, 892-898.
7. Zhang, J.; Chen, X.G.; Peng, W.B.; Liu, C.S. Uptake of oleoyl-chitosan nanoparticles by A549 cells. Nanomedicine 2008, 4, 208-214.
8. Wang, Q.; Zhang, L.; Hu, W.; Hu, Z.H.; Bei, Y.Y.; Xu, J.Y.; Wang, W.J.; Zhang, X.N.; Zhang, Q. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomedicine 2010, 6, 371-381.
9. Shi, L, Tang, C, Yin, C. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials 2012, 33, 7594-7604.
10. Wu, W.; Shen, J.; Banerjee, P.; Zhou, S. Chitosan-based responsive hybrid nanogels for integration of optical pH-sensing, tumor cell imaging and controlled drug delivery. Biomaterials 2010, 31, 8371-8381.
11. Kean, T.; Thanou, M. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug. Deliv. Rev. 2010, 62, 3-11.
12. Zhou, X.; Zhang, X.; Yu, X.; Zha, X.; Fu, Q.; Liu, B.; Wang, X.; Chen, Y.; Shan, Y.; Jin, Y.; et al. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. Biomaterials 2008, 29, 111-117.
13. Arca, H.C.; Gunbeyaz, M.; Senel, S. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev. Vaccines 2009, 8, 937-953.
14. Ramesan, R.M.; Sharma, C.P. Modification of chitosan nanoparticles for improved gene delivery. Nanomedicine 2012, 7, 5-8.
15. Shi, B.; Shen, Z.; Zhang, H.; Bi, J.; Dai, S. Exploring N-imidazolyl-O-carboxymethyl chitosan for high performance gene delivery. Biomacromolecules 2012, 13, 146-153.
16. Malmo, J.; Sorgard, H.; Varum, K.M.; Strand, S.P. siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing. J. Control. Release 2012, 158, 261-268.
17. Ta, H.T.; Dass, C.R.; Larson, I.; Choong, P.F.; Dunstan, D.E. A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy. Biomaterials 2009, 30, 4815-4823.
18. Park, J.S.; Na, K.; Woo, D.G.; Yang, H.N.; Kim, J.M.; Kim, J.H.; Chung, H.M.; Park, K.H. Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials 2010, 31, 124-132.
19. Ditto, A.J.; Shah, P.N.; Yun, Y.H. Non-viral gene delivery using nanoparticles. Expert Opin. Drug Deliv. 2009, 6, 1149-1160.
20. Song, B.; Zhang, W.; Peng, R.; Huang, J.; Nie, T.; Li, Y.; Jiang, Q.; Gao, R. Synthesis and cell activity of novel galactosylated chitosan as a gene carrier. Colloids Surf. B Biointerfaces 2009, 70, 181-186.
21. Kim, J.H.; Minai-Tehrani, A.; Kim, Y.K.; Shin, J.Y.; Hong, S.H.; Kim, H.J.; Lee, H.D.; Chang, S.H.; Yu, K.N.; Bang, Y.B.; et al. Suppression of tumor growth in H-ras12V liver cancer mice by delivery of programmed cell death protein 4 using galactosylated poly(ethylene glycol)-chitosan-graft-spermine. Biomaterials 2012, 33, 1894-1902.
22. Zhou, X.; Zhang, M.; Yung, B.; Li, H.; Zhou, C.; Lee, L.J.; Lee, R.J. Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma. Int. J. Nanomedicine 2012, 7, 5465-5474.
23. Cheng, M.; Han, J.; Li, Q.; He, B.; Zha, B.; Wu, J.; Zhou, R.; Ye, T.; Wang, W.; Xu, H.; et al. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies. J. Biomed. Mater. Res. B Appl. Biomater. 2012, 100, 2035-2043.
24. Kang, Y.; Wang, C.; Liu, K.; Wang, Z.; Zhang, X. Enzyme-responsive polymeric supra-amphiphiles formed by the complexation of chitosan and ATP. Langmuir 2012, 28, 14562-14566.
25. 31
26. Corbin, I.R.; Buist, R.; Peeling, J.; Zhang, M.; Uhanova, J.; Minuk, G.Y. Hepatic P MRS in rat models of chronic liver disease: Assessing the extent and progression of disease. Gut 2003, 52, 1046-1053.
27. 31P-MRS for evaluation of myocardial energy metabolism and function following coronary artery bypass graft. Magn. Reson. Imaging. 2010, 28, 936-942.
28. Corbin, I.R.; Ryner, L.N.; Singh, H.; Minuk, G.Y. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287, G379-G384.
29. Chung, T.W.; Yang, J.; Akaike, T.; Cho, K.Y.; Nah, J.W.; Kim, S.I.; Cho, C.S. Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials 2002, 23, 2827-2834.
30. Kamruzzaman Selim, K.M.; Ha, Y.S.; Kim, S.J.; Chang, Y.; Kim, T.J.; Ho Lee, G.; Kang, I.K. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials 2007, 28, 710-716.
31. Park, I.K.; Yang, J.; Jeong, H.J.; Bom, H.S.; Harada, I.; Akaike, T.; Kim, S.I.; Cho, C.S. Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment. Biomaterials 2003, 24, 2331-2337.
32. Jiang, H.L.; Kwon, J.T.; Kim, E.M.; Kin, Y.K.; Arote, R.; Jere, D.; Jeong, H.J.; Jang, M.K.; Nah, J.W.; Xu, C.X.; et al. Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. J. Control. Release 2008, 131, 150-157.
33. Kim, E.M.; Jeong, H.J.; Park, I.K.; Cho, C.S.; Moon, H.B.; Yu, D.Y.; Bom, H.S.; Sohn, M.H.; Oh, I.J. Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): In vitro and in vivo studies. J. Control. Release 2005, 108, 557-567.
34. Wei, W.; Yue, Z.G.; Qu, J.B.; Yue, H.; Su, Z.G.; Ma, G.H. Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: An in vitro evaluation. Nanomedicine 2010, 5, 589-596.
35. Jiang, H.L.; Kwon, J.T.; Kim, Y.K.; Kim, E.M.; Arote, R.; Jeong, H.J.; Nah, J.W.; Choi, Y.J.; Akaike, T.; Cho, M.H.; et al. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting. Gene. Ther. 2007, 14, 1389-1398.
36. Hu, F.Q.; Zhao, M.D.; Yuan, H.; You, J.; Du, Y.Z.; Zeng, S. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: Properties and in vitro transfection studies. Int. J. Pharm. 2006, 315, 158-166.
37. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24, 1121-1131.